← Back to All Stocks

Coherus Oncology, Inc. (CHRS) Analysis

Generated on: 2025-06-23 13:41:18 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$0.75
Predicted Price
$0.86
Expected Return
11.96%
Confidence Score
0.81
RSI (14)
45.94
MACD
-0.03
Volume
27,546
Float Shares
110,892,497
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

CHRS

Coherus Oncology, Inc.
11.96%
Price: $0.75
Confidence: 0.81
News
Last updated: 2025-06-23 13:41:18

Technical Analysis

RSI: 45.94
MACD: -0.03
Technical Analysis Graph

Risk Analysis

Volatility
101.07%
Max Drawdown
-62.78%
Beta
1.0
Risk Score
85.5

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
Insider Monkey - 2025-06-06 20:29
We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Steve Wagner’s Substack. In this article, we will summarize the bulls’ thesis on CHRS. Coherus BioSciences, Inc. (CHRS)’s share was trading at $0.77 as of 30th May. CHRS’s trailing P/E was 1.77 according to Yahoo Finance. Coherus BioSciences (CHRS), long overlooked by Wall Street, is […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.